Company Overview of Glyconix Corp.

Company Overview

Glyconix Corp., a development stage company, engages in the discovery of proprietary small molecule therapeutics and related carbohydrate chemistry, as well as in the development of proprietary L-p-Boronophenylalanine manufacturing and L-p-Boronophenylalanine delivery technologies. It focuses on developing proprietary pharmaceuticals for the treatment of cancer and infectious diseases. The company also supplies L-p-Boronophenylalanine to research institutes conducting Phase II and Phase III clinical trials of L-p-Boronophenylalanine-fructose, a small sugar molecule, in boron neutron capture therapy in cancers of the brain and other malignancies in the United States and internationally. In ad...

Glyconix Corp., a development stage company, engages in the discovery of proprietary small molecule therapeutics and related carbohydrate chemistry, as well as in the development of proprietary L-p-Boronophenylalanine manufacturing and L-p-Boronophenylalanine delivery technologies. It focuses on developing proprietary pharmaceuticals for the treatment of cancer and infectious diseases. The company also supplies L-p-Boronophenylalanine to research institutes conducting Phase II and Phase III clinical trials of L-p-Boronophenylalanine-fructose, a small sugar molecule, in boron neutron capture therapy in cancers of the brain and other malignancies in the United States and internationally. In addition, Glyconix applies its proprietary technology for meeting the needs of other companies in their management of pharmaceutical product life cycles. The company was formed in August 2001. It was formerly known as Glycosylation Technology, Inc. and changed its name to Glyconix Corp. in November 2001. Glyconix is based in New York, New York.

Key Executives for Glyconix Corp.

Similar Private Companies By Industry

Recent Private Companies Transactions